Xybion Digital Inc.
XYBN.V
Toronto Stock Exchange Ventures0.90
CAD
+0.02
- -
Xybion Digital Inc.
XYBN.V
(Toronto Stock Exchange Ventures)
Recent
price
0.90
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Xybion Digital Inc. delivers a comprehensive suite of software-as-a-service solutions, catering to the exacting requirements of life sciences and health systems organizations globally. Their offerings encompass an integrated array of digital tools, including Pristima Web, an advanced preclinical research and development management system that functions as a complete laboratory information management system (LIMS) for study oversight and drug safety evaluations. Additionally, Labwise XD provides laboratory operations software to streamline both GMP and non-GMP compliant process flows, while the broader Xybion LIMS offers adaptable management across diverse laboratory environments. The company also provides Xybion QMS, a unified cloud-based platform for robust quality, compliance, and risk management, alongside enterprise content management. Their Emidence XD system presents a comprehensive solution for workforce health and safety, facilitating incident reporting, OSHA compliance, and case management, particularly in workers' compensation scenarios. Further solutions include ECM XD for cloud-based enterprise content management, Savante for data warehousing, analytics, and preparing SEND-compliant data for regulatory submissions, and specialized tools like Compliance Risk Predictor and Compliance Builder for real-time risk assessment and monitoring. Xybion also integrates AI-powered solutions, known as Xybion AI, for enhanced insights, analytics, and intelligent automation. Beyond software, the company extends its expertise through professional services such as project management, computer system validation, and software development and testing. Serving a wide array of sectors including life sciences, pharmaceutical, biotechnology, contract research, health systems, and government agencies, Xybion Digital has a global footprint, assisting over 350 clients across 35 countries, including leading biopharmaceutical enterprises. The company, which was founded in 1977 and is based in Princeton, New Jersey, was acquired by Instem Group in July 2025 from Banerjee Group LLC, bringing together significant expertise in preclinical research and development. Prior to this, Xybion Digital Inc. completed a go-private transaction in June 2024, ceasing to be publicly traded on the TSX Venture Exchange.